Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| mature NK T cell | 5 studies | 24% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 17% ± 2% | |
| CD8-positive, alpha-beta T cell | 4 studies | 23% ± 7% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 17% ± 1% | |
| effector memory CD8-positive, alpha-beta T cell, terminally differentiated | 3 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of PATL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 98% | 102.93 | 87 / 89 | 61% | 1.68 | 546 / 901 |
| lung | 100% | 322.07 | 578 / 578 | 54% | 1.35 | 625 / 1155 |
| uterus | 96% | 84.84 | 164 / 170 | 42% | 0.91 | 195 / 459 |
| ovary | 91% | 75.66 | 164 / 180 | 47% | 1.07 | 203 / 430 |
| thymus | 96% | 150.56 | 624 / 653 | 43% | 0.90 | 258 / 605 |
| breast | 95% | 102.91 | 436 / 459 | 33% | 0.78 | 369 / 1118 |
| prostate | 97% | 133.88 | 237 / 245 | 30% | 0.55 | 149 / 502 |
| stomach | 88% | 88.35 | 316 / 359 | 36% | 0.69 | 103 / 286 |
| skin | 78% | 62.15 | 1419 / 1809 | 45% | 1.37 | 213 / 472 |
| esophagus | 69% | 44.76 | 1000 / 1445 | 52% | 1.17 | 95 / 183 |
| liver | 93% | 86.79 | 211 / 226 | 25% | 0.51 | 101 / 406 |
| intestine | 85% | 226.73 | 817 / 966 | 28% | 0.58 | 148 / 527 |
| adrenal gland | 99% | 199.21 | 256 / 258 | 11% | 0.24 | 26 / 230 |
| bladder | 76% | 86.33 | 16 / 21 | 30% | 0.60 | 149 / 504 |
| spleen | 100% | 1294.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 780.15 | 925 / 929 | 0% | 0 | 0 / 0 |
| adipose | 98% | 132.03 | 1180 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 41% | 23.17 | 135 / 328 | 49% | 1.16 | 88 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 6.54 | 25 / 29 |
| heart | 86% | 68.00 | 741 / 861 | 0% | 0 | 0 / 0 |
| brain | 32% | 17.78 | 845 / 2642 | 43% | 0.81 | 300 / 705 |
| blood vessel | 49% | 41.78 | 656 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 44% | 0.81 | 20 / 45 |
| eye | 0% | 0 | 0 / 0 | 18% | 0.49 | 14 / 80 |
| muscle | 9% | 4.50 | 76 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0033962 | Biological process | P-body assembly |
| GO_0010607 | Biological process | negative regulation of cytoplasmic mRNA processing body assembly |
| GO_0000290 | Biological process | deadenylation-dependent decapping of nuclear-transcribed mRNA |
| GO_0017148 | Biological process | negative regulation of translation |
| GO_0000932 | Cellular component | P-body |
| GO_1990904 | Cellular component | ribonucleoprotein complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | PATL2 |
| Protein name | Protein PAT1 homolog 2 (PAT1-like protein 2) (Protein PAT1 homolog a) (Pat1a) (hPat1a) HCG39323, isoform CRA_a (PAT1 homolog 2) PAT1 homolog 2 |
| Synonyms | hCG_39323 |
| Description | FUNCTION: RNA-binding protein that acts as a translational repressor. . |
| Accessions | ENST00000558809.1 H0YN77 ENST00000560110.1 H0YMS5 H0YNY1 H0YMQ2 ENST00000682850.1 C9JE40 ENST00000560780.1 ENST00000434130.6 ENST00000558481.5 |
